APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 54 filers reported holding APTEVO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $35,000 | -22.2% | 10,699 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $45,000 | +66.7% | 10,699 | -10.1% | 0.00% | – |
Q3 2017 | $27,000 | 0.0% | 11,899 | -9.2% | 0.00% | – |
Q2 2017 | $27,000 | -3.6% | 13,099 | -3.0% | 0.00% | – |
Q1 2017 | $28,000 | -15.2% | 13,499 | 0.0% | 0.00% | – |
Q4 2016 | $33,000 | -5.7% | 13,499 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $35,000 | – | 13,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,894,219 | $3,505,000 | 2.02% |
CVI Holdings, LLC | 780,720 | $703,000 | 0.67% |
Worth Venture Partners, LLC | 429,000 | $387,000 | 0.22% |
Sessa Capital IM, L.P. | 1,021,836 | $920,000 | 0.13% |
683 Capital Management, LLC | 575,000 | $518,000 | 0.05% |
Park West Asset Management LLC | 1,000,000 | $900,000 | 0.04% |
ATLAS CAPITAL ADVISORS LLC | 49,045 | $44,140,000 | 0.02% |
Point72 Asset Management, L.P. | 2,200,000 | $1,980,000 | 0.01% |
Alyeska Investment Group, L.P. | 750,000 | $675,000 | 0.01% |
Alyeska Investment Group, L.P. | 701,655 | $631,000 | 0.01% |